CCCX
Churchill Capital Corp X-A
NASDAQ · N/A
$11.66
+0.92 (+8.57%)
Open$11.31
Previous Close$10.74
Day High$11.82
Day Low$10.85
52W High$27.50
52W Low$10.03
Volume—
Avg Volume2.27M
Market Cap606.90M
P/E Ratio—
EPS$-0.61
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 377.06M | 353.35M | 309.67M |
| Net Income | 46.76M | 35.75M | 36.05M |
| Profit Margin | 12.4% | 10.1% | 11.6% |
| EBITDA | 57.07M | 51.63M | 50.21M |
| Free Cash Flow | 46.45M | 42.52M | 46.04M |
| Rev Growth | -2.7% | +10.3% | -0.7% |
| Debt/Equity | 0.35 | 0.35 | 0.32 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $6.13 | +4.25% | — | 3.64B |
| PICS | Pics Nv | $15.73 | +4.73% | — | 2.04B |
| DMII | Drugs Made In America Acquis | $9.99 | -0.20% | — | 655.09M |
| BEAG | Bold Eagle Acquisition Cor-A | $10.53 | +0.10% | 63.0 | 605.14M |
| CEPF | Cantor Equity Partners-Cl A | $10.46 | +0.48% | 364.8 | 597.79M |
| BCSS | Bain Capital Gss Inv- A | $10.16 | +0.00% | — | 593.34M |